For the ROL100 ranking, Fortune partnered with Indiggo. The ranking assessed organizations’ “capacity for execution through its leaders and managers” based on connection to purpose, strategic clarity, leadership alignment, and focused action.
Fortune said a mix of three to five key indicators is assessed for each of the four drivers to determine the overall Return on Leadership score and ranking for each company. More information about the methodology is available here.
The eight healthcare companies that cracked the top 25 of the ROL100:
Thermo Fisher Scientific (No. 4 in ROL100 ranking)
Pfizer (No. 5 in ROL100 ranking)
HCA Healthcare (No. 8 in ROL100 ranking)
Elevance Health (No. 9 in ROL100 ranking)
UnitedHealth Group (No. 11 in ROL100 ranking)
Merck (No. 15 in ROL100 ranking)
Humana (No. 18 in ROL100 ranking)
Bristol-Myers Squibb (No. 24 in the ROL100 ranking)